Genova Therapeutics is reimagining healthcare through next-generation gene-editing solutions. Their CRISPR-based platform develops targeted therapies for rare and chronic diseases that previously had limited treatment options. With a focus on precision medicine, Genova is working on therapies that drastically reduce time-to-market while ensuring patient safety.